Adaptimmune Therapeutics Plc (ADAP)

Market is closed

Insider Trading: Purchases

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
New	$1.81	104,844	Large Shareholder	72,243,844	2018-03-21	Filing
Thompson	$4.20	1,190,476	Director	6,149,377	2017-03-27	Filing
Orbimed	$4.20	1,190,476	Director	6,149,377	2017-03-27	Filing
Viswanathan	$0.70	12,870,000	Large Shareholder	72,139,000	2017-03-27	Filing
Sonsini	$0.70	12,870,000	Large Shareholder	72,139,000	2017-03-27	Filing
Sandell	$0.70	12,870,000	Large Shareholder	72,139,000	2017-03-27	Filing
Mott	$0.70	12,870,000	Large Shareholder, Director	72,139,000	2017-03-27	Filing
Kerins	$0.70	12,870,000	Large Shareholder	72,139,000	2017-03-27	Filing
Florence	$0.70	12,870,000	Large Shareholder	72,139,000	2017-03-27	Filing
Baskett	$0.70	12,870,000	Large Shareholder	72,139,000	2017-03-27	Filing
Barris	$0.70	12,870,000	Large Shareholder	72,139,000	2017-03-27	Filing
Barrett	$0.70	12,870,000	Large Shareholder	72,139,000	2017-03-27	Filing
New	$0.70	12,870,000	Large Shareholder	72,139,000	2017-03-27	Filing
Thompson	$10.48	518,400	Director	29,753,404	2016-05-24	Filing
Thompson	$10.40	1,191,600	Director	29,235,004	2016-05-23	Filing
Thompson	$10.04	2,400	Director	28,043,404	2016-05-20	Filing
Orbimed	$10.48	518,400	Director	29,753,404	2016-05-24	Filing
Orbimed	$10.40	1,191,600	Director	29,235,004	2016-05-23	Filing
Orbimed	$10.04	2,400	Director	28,043,404	2016-05-20	Filing
Sigal	$1.56	15,000	Director	314,100	2016-05-19	Filing